Showing results (311-320 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|December 29, 2012
The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenograftsEzia Bello, Giulia Taraboletti, Gennaro Colella, et al.
Molecular Cancer Therapeutics|December 29, 2012
VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancerStefan Hart, Veronica Novotny-Diermayr, Kee Chuan Goh, et al.
Molecular Cancer Therapeutics|February 22, 2012
Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancerMickey K Kim, Takuya Osada, William T Barry, et al.
Molecular Cancer Therapeutics|March 31, 2012
IGF-1R/MDM2 relationship confers enhanced sensitivity to RITA in Ewing sarcoma cellsGiusy Di Conza, Marianna Buttarelli, Olimpia Monti, et al.
Molecular Cancer Therapeutics|February 2, 2013
EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristicsMaria E Arcila, Khedoudja Nafa, Jamie E Chaft, et al.
Molecular Cancer Therapeutics|February 2, 2013
The HSP70 and autophagy inhibitor pifithrin-μ enhances the antitumor effects of TRAIL on human pancreatic cancerHiroyuki Monma, Nanae Harashima, Touko Inao, et al.
Molecular Cancer Therapeutics|February 28, 2013
FOX(M1) news--it is cancerMarianna Halasi, Andrei L Gartel
Molecular Cancer Therapeutics|February 28, 2013
A phase II study of temozolomide in patients with advanced aerodigestive tract and colorectal cancers and methylation of the O6-methylguanine-DNA methyltransferase promoterDaniel Hochhauser, Rob Glynne-Jones, Vanessa Potter, et al.
Molecular Cancer Therapeutics|February 12, 2013
GX15-070 (obatoclax) induces apoptosis and inhibits cathepsin D- and L-mediated autophagosomal lysis in antiestrogen-resistant breast cancer cellsJessica L Schwartz-Roberts, Ayesha N Shajahan, Katherine L Cook, et al.
Molecular Cancer Therapeutics|May 31, 2013
Pharmacologic activation of PKM2 slows lung tumor xenograft growthK Mark Parnell, Jason M Foulks, Rebecca N Nix, et al.
Pageof 599